GYL Financial Synergies’s Elevance Health ELV Stock Holding History

GYL Financial Synergies’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$236K	Buy	+454	New	+$243K	0.02%	333

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GYL Financial Synergies's ELV Position: Q3 2024 in Review

GYL Financial Synergies opened a new position in Elevance Health (ELV) in Q3 2024: 454 shares worth $236K. The stake represents 0.02% of the portfolio and ranks #333 among its holdings.

1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

GYL Financial Synergies held 454 shares of Elevance Health worth $236K as of Q3 2024.
Elevance Health was a new GYL Financial Synergies position in Q3 2024.
Elevance Health made up 0.02% of GYL Financial Synergies's portfolio in Q3 2024, its #333 holding.
1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on GYL Financial Synergies's 13F filing for Q3 2024, filed 7 Nov 2024.